Category: Pharmaceuticals
Pharmaceuticals market research reports by DelveInsight
-
Ophthalmic Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030
Ophthalmic Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030 Ophthalmic Lasers Market by Product Type (Argon Blue-Green Laser, ND: Yag Laser, Femtosecond Lasers, Krypton Red Laser, and Others), Application (Glaucoma, Diabetic Retinopathy, Cataracts, and Others), End-User (H ... Read More
-
Ebola Virus- Competitive Landscape, 2024
Ebola Virus- Competitive Landscape, 2024 DelveInsight’s, “Ebola Virus- Competitive landscape, 2024,” report provides comprehensive insights about 18+ companies and 20+ drugs in Ebola Virus Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, a ... Read More
-
Erectile Dysfunction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
Erectile Dysfunction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Erectile Dysfunction Devices Market by Product (Penile Implants, Shockwave Therapy Devices, Vacuum Therapy Devices, and Others), Approach (Invasive, Non-Invasive), End-User (Hospitals and Clinics, Ambul ... Read More
-
Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Ophthalmic Devices Market by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, a ... Read More
-
Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 Deep Brain Stimulation Devices Market by Product Type (Single Channel and Dual Channel), Battery Type (Rechargeable and Non-Rechargeable), Application (Parkinson’s Disease, Epilepsy, Obsessive Compuls ... Read More
-
Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030
Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030 Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals ... Read More
-
Dengue Fever- Pipeline Insight, 2024
Dengue Fever- Pipeline Insight, 2024 DelveInsight’s, “Dengue Fever- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Dengue Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More
-
Psoriatic Arthritis - Pipeline Insight, 2024
Psoriatic Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Psoriatic Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More
-
Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034
Autoimmune Psychosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight’s “Autoimmune Psychosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Autoimmune Psychosis, historical and forecasted epidemiology as well as the ... Read More
-
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, there were an estimated 42 million prevalent cases of MASH in the 7MM. Out of these, a total of ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in t ... Read More
-
Pre-Eclampsia - Pipeline Insight, 2024
Pre-Eclampsia - Pipeline Insight, 2024 DelveInsight’s, “Pre-Eclampsia - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More
-
Schizophrenia - Pipeline Insight, 2024
Schizophrenia - Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More
-
Type 2 Diabetes - Pipeline Insight, 2024
Type 2 Diabetes - Pipeline Insight, 2024 DelveInsight’s, “Type 2 Diabetes - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Type 2 Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
Cutaneous T-cell lymphoma - Pipeline Insight, 2024 DelveInsight’s, “Cutaneous T-cell lymphoma- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Cutaneous T-cell lymphoma pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
-
Lou Gehrig’s disease - Pipeline Insight, 2024
Lou Gehrig’s disease - Pipeline Insight, 2024 DelveInsight’s, “Lou Gehrig’s disease - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
-
Myotonic Dystrophy - Pipeline Insight, 2024
Myotonic Dystrophy - Pipeline Insight, 2024 DelveInsight’s, “Myotonic Dystrophy - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 27+ pipeline drugs in Myotonic Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More
-
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 4 ... Read More
-
Smoking Cessation- Pipeline Insight, 2024
Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More
-
Lupus Nephritis - Pipeline Insight, 2024
Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 1,028,651 diagnosed prevalent cases of NCFB in the 7MM. Of these, the US accounted for approximately 37% of the cases, EU4 and the ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). This growth is primarily d ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting for approximately USD 12 billion which is further expected to rise at a CAGR of 2. ... Read More
-
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for ITP was estimated to be nearly USD 4,100 million in 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parainfluenza virus infection market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of parainfluenza virus infection in the 7MM is expected to ... Read More
-
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parkinson’s disease Psychosis (PDP) market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of PDP in the 7MM is expected to increase, driven by better ... Read More